Skip to content

KIDEPHAR: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

KIDEPHAR

BE 0452.044.843
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€13,992
2024 · -€12,672-€1,320
Equity
€53,099
2024 · €67,090-€13,992
Cash
€21,185
2024 · €43,335-€22,150
Balance sheet total
€81,623
2024 · €115,069-€33,447

Largest movements

2024 to 2025
Assets
  • Cash -€22,150

    down €22,150 (-51.1%), from €43,335 to €21,185

    mainly Other debts (-€18,327) and Net result for the year (-€13,992)

  • Receivables within one year -€5,063

    down €5,063 (-28.1%), from €18,048 to €12,985

    of which Trade receivables: -€7,431

  • Stocks and contracts -€4,558

    down €4,558 (-10.1%), from €45,345 to €40,788

  • Tangible fixed assets -€1,674

    down €1,674 (-24.0%), from €6,979 to €5,305

Equity and liabilities
  • Other debts -€18,327

    down €18,327 (-46.3%), from €39,583 to €21,255

  • Profit (loss) carried forward -€13,992

    down €13,992 (-55.7%), from -€25,107 to -€39,099

Income statement
  • Gross operating margin -€5,712

    down €5,712 (-305.6%), from -€1,869 to -€7,581

  • Staff costs -€3,356

    down €3,356 (-100.0%), from €3,356 to €0

  • Other operating charges -€373

    down €373 (-9.0%), from €4,135 to €3,762

  • Depreciation -€353

    down €353 (-17.4%), from €2,027 to €1,674

  • Financial income +€202

    up €202 (+195.9%), from €103 to €305

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€12,672
Gross operating margin -€5,712
Staff costs +€3,356
Depreciation +€353
Other operating charges +€373
Financial income +€202
Financial charges +€97
Taxes +€10
Result 2025 -€13,992

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€22,150
Investment €0
Financing €0
Cash 2024 €43,335
Net result for the year -€13,992
Depreciation +€1,674
Stocks and contracts +€4,558
Receivables within one year +€5,063
Smaller working-capital items -€21
Trade debts -€1,105
Other debts -€18,327
Cash 2025 €21,185
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €115,069 €81,623 -€33,447 -29.1%
Fixed assets 21/28 €6,979 €5,305 -€1,674 -24.0%
Tangible fixed assets 22/27 €6,979 €5,305 -€1,674 -24.0%
Land and buildings 22 €2,232 €1,674 -€558 -25.0%
Plant, machinery and equipment 23 €3,003 €2,644 -€359 -12.0%
Furniture and vehicles 24 €1,744 €987 -€756 -43.4%
Current assets 29/58 €108,091 €76,318 -€31,773 -29.4%
Stocks and contracts in progress 3 €45,345 €40,788 -€4,558 -10.1%
Stocks 30/36 €45,345 €40,788 -€4,558 -10.1%
Amounts receivable within one year 40/41 €18,048 €12,985 -€5,063 -28.1%
Trade receivables 40 €7,431 €0 -€7,431 -100.0%
Other amounts receivable 41 €10,617 €12,985 +€2,369 +22.3%
Cash at bank and in hand 54/58 €43,335 €21,185 -€22,150 -51.1%
Deferred charges and accrued income 490/1 €1,362 €1,360 -€2 -0.2%
Total equity and liabilities 10/49 €115,069 €81,623 -€33,447 -29.1%
Equity 10/15 €67,090 €53,099 -€13,992 -20.9%
Contributions 10/11 €78,813 €78,813 = 0.0%
Reserves 13 €13,385 €13,385 = 0.0%
Distributable reserves 133 €13,385 €13,385 = 0.0%
Profit (loss) carried forward 14 -€25,107 -€39,099 -€13,992 -55.7%
Amounts payable 17/49 €47,979 €28,524 -€19,455 -40.5%
Amounts payable within one year 42/48 €47,979 €28,524 -€19,455 -40.5%
Trade debts 44 €6,615 €5,511 -€1,105 -16.7%
Suppliers 440/4 €6,615 €5,511 -€1,105 -16.7%
Taxes, remuneration and social security 45 €1,781 €1,758 -€23 -1.3%
Taxes 450/3 €1,781 €1,758 -€23 -1.3%
Remuneration and social security 454/9 €0 - =
Other amounts payable 47/48 €39,583 €21,255 -€18,327 -46.3%
Remuneration, social security and pensions 62 €3,356 €0 -€3,356 -100.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,027 €1,674 -€353 -17.4%
Other operating charges 640/8 €4,135 €3,762 -€373 -9.0%
Gross operating margin 9900 -€1,869 -€7,581 -€5,712 -305.6%
Operating profit (loss) 9901 -€11,387 -€13,017 -€1,629 -14.3%
Financial income 75/76B €103 €305 +€202 +195.9%
Recurring financial income 75 €103 €305 +€202 +195.9%
Financial charges 65/66B €804 €707 -€97 -12.1%
Recurring financial charges 65 €804 €707 -€97 -12.1%
Profit (loss) for the period before taxes 9903 -€12,088 -€13,418 -€1,330 -11.0%
Income taxes 67/77 €584 €573 -€10 -1.7%
Profit (loss) for the period 9904 -€12,672 -€13,992 -€1,320 -10.4%
Profit (loss) for the period to be appropriated 9905 -€12,672 -€13,992 -€1,320 -10.4%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.